BlackRock Japan’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

BlackRock Japan’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19K	Sell	1,792 -70	-4%	-$700	﹤0.01%	1139
2016 Q3	$19K	Sell	1,862 -19	-1%	-$207	﹤0.01%	1137
2016 Q2	$25K	Sell	1,881 -2,198	-54%	-$28.8K	﹤0.01%	1131
2016 Q1	$45K	Sell	4,079 -3,769	-48%	-$33.5K	﹤0.01%	1054
2015 Q4	$72K	Sell	7,848 -628	-7%	-$5.26K	﹤0.01%	968
2015 Q3	$59K	Hold	8,476	–	–	﹤0.01%	942
2015 Q2	$83K	Buy	8,476 +5,759	+212%	+$52.5K	﹤0.01%	999
2015 Q1	$24K	Buy	+2,717	New	+$21.6K	﹤0.01%	1170
2014 Q2	–	Sell	-21,963	Closed	-$100K	–	1474
2014 Q1	$100K	Sell	21,963 -29,356	-57%	-$142K	﹤0.01%	1064
2013 Q4	$259K	Sell	51,319 -9,737	-16%	-$46.9K	﹤0.01%	869
2013 Q3	$310K	Buy	61,056 +47,674	+356%	+$265K	﹤0.01%	820
2013 Q2	$66K	Buy	+13,382	New	+$63.7K	﹤0.01%	1043

Other funds holding SCLN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BlackRock Japan's SCLN Position: Q4 2016 in Review

BlackRock Japan reduced its Sciclone Pharmaceuticals Inc (SCLN) stake by 3.8% in Q4 2016, selling an estimated $700 and leaving 1,792 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

BlackRock Japan first reported a position in SCLN in Q2 2013 and has held it in 12 quarters since. The position peaked at $310K in Q3 2013. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

BlackRock Japan held 1,792 shares of Sciclone Pharmaceuticals Inc worth $19K as of Q4 2016.
BlackRock Japan sold 70 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $700.
Sciclone Pharmaceuticals Inc made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1139 holding.
BlackRock Japan first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and has held it in 12 quarters since.
BlackRock Japan's Sciclone Pharmaceuticals Inc position peaked at $310K in Q3 2013.
153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.